With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Need to harmonize traditional and modern medicine to combat alarming health problems
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
CiplaMed 2.0 leverages advanced analytics and automation
Subscribe To Our Newsletter & Stay Updated
